Trial · NCT01660893
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Completion of the Study Dental Procedure Without Need for Rescue by Injection of Local Anesthetic (Yes/no). | at 15 minutes with a 3 minute window | |
| Secondary | Intraoral Soft-tissue Anesthesia (Yes/no) | at 15 minutes with a 3 minute window | Number of patients who reported no pain when incisive papilla and greater palatine foramen soft-tissue was tested with a probe |
| Secondary | Number of Participants With Heart Rate Higher Than 125 Bpm | at any time within 120 minutes following drug administration | |
| Secondary | Number of Participants With Heart Rate Lower Than 50 Bpm | at any time within 120 minutes following drug administration | |
| Secondary | Number of Participants With an Increase From Baseline in Systolic Blood Pressure Greater Than or Equal to 25 mm Hg and to a Value Higher Than 160 mm Hg | at any time within 120 minutes following drug administration | |
| Secondary | Number of Participants With a Decrease From Baseline in Systolic Blood Pressure Greater Than or Equal to 15 mm Hg and to a Value Lower Than 90 mm Hg | at any time within 120 minutes following drug administration | |
| Secondary | Number of Participants With an Increase From Baseline in Diastolic Blood Pressure Greater Than or Equal to 15 mm Hg and to a Value Higher Than 90 mm Hg | at any time within 120 minutes following drug administration | |
| Secondary | Number of Participants With a Decrease From Baseline in Diastolic Blood Pressure Greater Than or Equal to 15 mm Hg and to a Value Lower Than 90 mm Hg | at any time within 120 minutes following drug administration | |
| Secondary | Absolute Maximum Change From Baseline in Systolic Blood Pressure and Diastolic Blood Pressure | from baseline to 120 minutes following drug administration | |
| Secondary | The Profile Over Time of Heart Rate | from baseline to 120 minutes following drug administration | |
| Secondary | Alcohol Sniff Test | administered at approximately 24 hours after drug administration | The change from screening in the the distance from the nose (in centimeters) that a patient is able to detect the smell of an alcohol swab. |
| Secondary | The Profile Over Time of Systolic Blood Pressure | from baseline to 120 minutes following drug administration | |
| Secondary | The Profile Over Time of Diastolic Blood Pressure | from baseline to 120 minutes following drug administration | |
| Secondary | Absolute Maximum Change From Baseline in Heart Rate | from baseline to 120 minutes following drug administration |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01660893/registered